US2006074128A1PendingUtilityA1
Substituted 2-phenyl benzofurans as estrogenic agents
Est. expiryDec 18, 2021(expired)· nominal 20-yr term from priority
Inventors:Christopher MillerMichael D. ColliniDavid KaufmanRobert L. MorrisRobert R. Singhaus, Jr.John W. UllrichHeather HarrisJames KeithLeo AlbertRayomand Jal Unwalla
A61P 3/10A61P 9/10A61P 5/30A61P 37/06A61P 39/06A61P 7/00A61P 9/00A61P 35/00A61P 3/06A61P 9/12A61P 5/00A61P 9/14A61P 25/00A61P 27/02A61P 29/00A61P 3/00A61P 25/22A61P 25/28C07D 413/04C07D 307/80A61P 1/04A61P 1/00A61P 17/02C07D 405/06A61P 17/06A61P 13/08A61P 13/02A61P 17/00A61P 11/06A61P 1/02A61P 19/02A61P 11/00A61P 15/18A61P 13/10A61P 15/00A61P 13/00
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides estrogen receptor modulators of formula 1, having the structure wherein R, R′, A, A′, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . A method of treating or inhibiting arthritis in a mammal in need thereof, which comprises providing to said mammal an effective amount of a compound of formula I, having the structure
wherein
P and P′ are each, independently, hydrogen, alkyl of 1-6 carbon atoms, or acyl of 2-7 carbon atoms;
X is hydrogen or halogen;
R is hydrogen, alkyl of 1-6 carbon atoms, halogen, —CN, or —CHO;
R′ is alkoxy of 1-6 carbon atoms, or cyanoalkyl having 1-6 carbon atoms in the alkyl moiety;
or a pharmaceutically acceptable salt thereof.
17 . The method according to claim 16 , wherein the arthritis is rheumatoid arthritis, osteoarthritis or spondyloarthropathies.
18 . A method of treating or inhibiting joint swelling or erosion; or treating or inhibiting joint damage secondary to arthroscopic or surgical procedures in a mammal in need thereof, which comprises providing to said mammal an effective amount of a compound of formula I, having the structure
wherein
P and P′ are each, independently, hydrogen, alkyl of 1-6 carbon atoms, or acyl of 2-7 carbon atoms;
X is hydrogen or halogen;
R is hydrogen, alkyl of 1-6 carbon atoms, halogen, —CN, or —CHO;
R′ is alkoxy of 1-6 carbon atoms, or cyanoalkyl having 1-6 carbon atoms in the alkyl moiety;
or a pharmaceutically acceptable salt thereof.
19 - 22 . (canceled)Join the waitlist — get patent alerts
Track US2006074128A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.